Prospective randomized controlled trial to compare 3‐dimensional conformal radiotherapy to intensity‐modulated radiotherapy in head and neck squamous cell carcinoma: Long‐term results
Sarbani Ghosh Laskar(Tata Memorial Hospital), Jai Prakash Agarwal(Tata Memorial Hospital), Debnarayana Dutta(Apollo Hospitals), Vedang Murthy(Homi Bhabha National Institute), Nilendu Purandare(Tata Memorial Hospital), Ashwini Budrukkar(Tata Memorial Hospital), Sadhana Kannan(Homi Bhabha National Institute), Tejpal Gupta(Tata Memorial Hospital), Prahlad H. Yathiraj(Kasturba Medical College, Manipal), Venkatesh Rangarajan(Tata Memorial Hospital)
Cited by 116
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340